000
| 01141nam 2200289za 4500 |
---|
001 | 9.815708 |
---|
003 | CaOODSP |
---|
005 | 20221107142058 |
---|
007 | cr ||||||||||| |
---|
008 | 180223s2017 onca ob f000 0 eng d |
---|
020 | |a978-0-660-05248-9 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aFR5-38/4-2016E-PDF |
---|
245 | 00|aInvest in Canada - Canada’s competitive advantages |h[electronic resource] : |bbiopharmaceuticals. |
---|
246 | 30|aBiopharmaceuticals |
---|
260 | |aOttawa : |bGlobal Affairs Canada, |c2017. |
---|
300 | |a[6] p. : |bcol. ill. |
---|
500 | |aIssued also in French under title: Investir au Canada - avantages concurrentiels du Canada : le secteur biopharmaceutique. |
---|
500 | |aCover title. |
---|
500 | |a"Spring 2017." |
---|
504 | |aIncludes bibliographical references. |
---|
692 | 07|2gccst|aPharmaceutical industry |
---|
692 | 07|2gccst|aForeign investments |
---|
710 | 1 |aCanada. |bGlobal Affairs Canada. |
---|
775 | 08|tInvestir au Canada - avantages concurrentiels du Canada |w(CaOODSP)9.815709 |
---|
856 | 40|qPDF|s1.82 MB|uhttps://publications.gc.ca/collections/collection_2018/amc-gac/FR5-38-4-2016-eng.pdf |
---|